Kezar Life Sciences (KZR) EBITDA (2017 - 2026)
Kezar Life Sciences (KZR) EBITDA from Jun 30, 2017 to Mar 31, 2026. The TTM Kezar Life Sciences (KZR) EBITDA is -$48M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Kezar Life Sciences (KZR) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -42.33% |
| 3 Years TTM | -15.19% |
| 5 Years TTM | +1.83% |
| All Time TTM | +17.46% |
Annual EBITDA change of Kezar Life Sciences (KZR)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$7.32M | -87.42% |
| 2025 | -$58M | -35.00% |
| 2024 | -$90M | -18.85% |
| 2023 | -$110M | +57.34% |
| 2022 | -$70M | +31.97% |
| 2021 | -$53M | +28.35% |
| 2020 | -$41M | +14.90% |
| 2019 | -$36M | +49.92% |
| 2018 | -$24M | +180.51% |
| 2017 | -$8.57M | -3.05% |
| 2016 | -$8.84M | N/A |
Comparison Kezar Life Sciences (KZR) five years EBITDA CAGR with competitors
Kezar Life Sciences (KZR) five years EBITDA CAGR is 1.83%.